The Impact of Age and Fitness on Reperfusion Injury and Ischemic Preconditioning to Prevent This Injury
1 other identifier
observational
30
1 country
1
Brief Summary
Rationale: Ischaemic preconditioning (IP) refers to the reduction of ischemia-reperfusion injury induced by a brief preceding period of ischemia. Also the arterial endothelium can be protected by IP. Several studies performed in animals and humans have demonstrated that the protective effects of IP are attenuated with aging. However, no previous study directly examined the underlying mechanisms of this observation. Possibly, the reduced protective effect of IP with aging relates to a direct effect on the endothelium, consequently leading to an attenuated ability of IP to prevent endothelial dysfunction after ischaemia reperfusion injury. Several previous studies failed to demonstrate the ability of pharmacological stimuli to mimic the beneficial effects of IP in aged vessels. Restoration of the age-related reduction in effectiveness of IP may be possible through exercise training. In aged animals, physical training restores the efficacy of ischemic preconditioning. Indirect evidence indicates that physical activity, independent of other cardiovascular risk factors, protects against a occurrence as well as the severity of a myocardial infarction in humans. Although this suggests that physical activity may beneficially influence the age-related reduction in IP, no previous study provided direct evidence for this hypothesis. Objective: To examine the impact of age and physical fitness on the ability of ischaemic preconditioning to protect endothelial damage in response to ischaemia reperfusion injury in healthy humans. A secondary objective is to explore the role of Toll-like receptor (TLR) signalling in the induction of IP in young and old subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2011
CompletedFirst Submitted
Initial submission to the registry
May 23, 2012
CompletedFirst Posted
Study publicly available on registry
May 25, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedNovember 20, 2013
November 1, 2013
2.6 years
May 23, 2012
November 19, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
endothelial reperfusion injury
Change in endothelial function (measured with flow mediated dilation) after ischaemia reperfusion injury (induced by 20 minutes ischemia) with and without precedence of ischaemic preconditioning (by 3 cycles of 5-minutes of ischaemia).
cross-sectional observation (single time point)
Study Arms (4)
young, sedentary
young, active
old, sedentary
old, active
Interventions
repeated cuff inflation (220 mmhg) around an upper limb for 5 minutes, followed by 5 minutes of reperfusion (repeated 4 times)
Eligibility Criteria
Study population: Young sedentary volunteers (n=23, age 18-30), young active volunteers (n=23, age 18-30), older sedentary subjects (n=23, \>55 years) and older physically active subjects (n=23, \>55 years).
You may qualify if:
- Healthy young volunteers : age 18-30
- Healthy older volunteers: age \>55 years
- Sedentary: \<1 h exercise per week
- Trained: \>5 h exercise per week
- All subjects: written informed consent
You may not qualify if:
- Smoking
- History of any cardiovascular disease
- Hypertension (in supine position: systole \>140 mmHg, diastole \>90 mmHg)
- Diabetes Mellitus (fasting glucose \>7.0 mmol/L or random glucose \>11.0 mmol/L)
- Hyperlipidaemia (fasting total cholesterol \>6.5 mmol/L)
- Chronic use of medication known to interfere with the cardiovascular system
- Professional athletes
- BMI \>30 kg/m2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Physiology
Nijmegen, 6525 EX, Netherlands
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Dick Thijssen, PhD
Radboud University Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2012
First Posted
May 25, 2012
Study Start
April 1, 2011
Primary Completion
November 1, 2013
Study Completion
November 1, 2013
Last Updated
November 20, 2013
Record last verified: 2013-11